LAMA2-related muscular dystrophy
|
LAMA2 |
Leber congenital amaurosis 10/CEP290-related conditions
|
CEP290 |
Leber congenital amaurosis 13
|
RDH12 |
Leber congenital amaurosis 2
|
RPE65 |
Leber congenital amaurosis 5
|
LCA5 |
Leber congenital amaurosis 8/CRB1-related disorders
|
CRB1 |
Lethal congenital contracture syndrome 1/lethal arthrogryposis with anterior horn cell disease
|
GLE1 |
Leukoencephalopathy with vanishing white matter (EIF2B5-related)
|
EIF2B5 |
Limb-girdle muscular dystrophy type 2A (calpainopathy)
|
CAPN3 |
Limb-girdle muscular dystrophy type 2C
|
SGCG |
Limb-girdle muscular dystrophy type 2D
|
SGCA |
Limb-girdle muscular dystrophy type 2E
|
SGCB |
Lipoid congenital adrenal hyperplasia
|
STAR |
Long chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency
|
HADHA |
Lysinuric protein intolerance
|
SLC7A7 |
Lysosomal acid lipase deficiency
|
LIPA |
Major histocompatibility complex class II deficiency
|
CIITA |
Maple syrup urine disease (MSUD) type 1A
|
BCKDHA |
Maple syrup urine disease (MSUD) type 1B
|
BCKDHB |
Maple syrup urine disease (MSUD), type 2
|
DBT |
Medium chain acyl-CoA dehydrogenase (MCAD) deficiency
|
ACADM |
Megalencephalic leukoencephalopathy with subcortical cysts type 1
|
MLC1 |
Menkes disease/ATP7A-related disorders (including occipital horn syndrome and distal hereditary motor
neuropathy) |
ATP7A |
Metachromatic leukodystrophy
|
ARSA |
Methylmalonic acidemia (MMAA-related)
|
MMAA |
Methylmalonic acidemia (MMAB-related)
|
MMAB |
Methylmalonic acidemia (MUT-related)
|
MUT |
Methylmalonic acidemia with homocystinuria, cobalamin C type
|
MMACHC |
Methylmalonic acidemia with homocystinuria, cobalamin D type
|
MMADHC |
Microphthalmia/clinical anophthalmia
|
VSX2 |
Mitochondrial complex I deficiency/Leigh syndrome (NDUFAF5-related)
|
NDUFAF5 |
Mitochondrial complex I deficiency/Leigh syndrome (NDUFS6-related) |
NDUFS6 |
Mitochondrial complex IV deficiency/Leigh syndrome, French Canadian type
|
LRPPRC |
Mitochondrial DNA depletion syndrome
|
MPV17 |
Mitochondrial myopathy and sideroblastic anemia 1 |
PUS1 |
Mitochondrial neurogastrointestinal encephalopathy (MNGIE) disease
|
TYMP |
MKS1-related disorders
|
MKS1 |
Mucolipidosis type III (GNPTG-related)
|
GNPTG |
Mucolipidosis type II/III (GNPTAB-related)
|
GNPTAB |
Mucolipidosis type IV
|
MCOLN1 |
Mucopolysaccharidosis type II (Hunter syndrome)
|
IDS |
Mucopolysaccharidosis type IIIA (Sanfilippo A syndrome)
|
SGSH |
Mucopolysaccharidosis type IIIB
|
NAGLU |
Mucopolysaccharidosis type IIIC (Sanfilippo syndrome)/retinitis pigmentosa 73
|
HGSNAT |
Mucopolysaccharidosis type IIID (Sanfilippo syndrome)
|
GNS |
Mucopolysaccharidosis type I (including Hurler, Hurler-Scheie, and Scheie syndromes)
|
IDUA |
Mucopolysaccharidosis type IVB/ GM1 gangliosidosis
|
GLB1 |
Mucopolysaccharidosis type IX
|
HYAL1 |
Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome)
|
ARSB |
Multiple sulfatase deficiency
|
SUMF1 |
Myotubular myopathy, X-linked |
MTM1 |
N-acetylglutamate synthase deficiency
|
NAGS |
Nemaline myopathy 2
|
NEB |
Nephrogenic diabetes insipidus (AQP2-related)
|
AQP2 |
Nephrotic syndrome/congenital Finnish nephrosis (NPHS1-related)
|
NPHS1 |
Nephrotic syndrome/steroid-resistant nephrotic syndrome (NPHS2-related)
|
NPHS2 |
Neuronal ceroid-lipofuscinosis (CLN3-related)
|
CLN3 |
Neuronal ceroid-lipofuscinosis (CLN5-related)
|
CLN5 |
Neuronal ceroid-lipofuscinosis (CLN6-related)
|
CLN6 |
Neuronal ceroid-lipofuscinosis (MFSD8-related)
|
MFSD8 |
Neuronal ceroid-lipofuscinosis/northern epilepsy (CLN8-related)
|
CLN8 |
Neuronal ceroid-lipofuscinosis (PPT1-related)
|
PPT1 |
Neuronal ceroid-lipofuscinosis (TPP1-related)
|
TPP1 |
Niemann-Pick disease type A/B
|
SMPD1 |
Niemann-Pick disease type C (NPC1-related)
|
NPC1 |
Niemann-Pick disease type C (NPC2-related)
|
NPC2 |
Nijmegen breakage syndrome
|
NBN |
NR2E3-related conditions (including enhanced S-cone syndrome)
|
NR2E3 |
OPA3-related conditions (including 3-methylglutaconic aciduria type III/Costeff syndrome)
|
OPA3 |
Ornithine aminotransferase deficiency
|
OAT |
Ornithine transcarbamylase (OTC) deficiency
|
OTC |
Osteopetrosis (TCIRG1-related)
|
TCIRG1 |
Pendred syndrome
|
SLC26A4 |
Peroxisomal acyl-CoA oxidase deficiency |
ACOX1 |
Phenylalanine hydroxylase deficiency (including PKU)
|
PAH |
Phosphoglycerate dehydrogenase deficiency/Neu-Laxova syndrome
|
PHGDH |
Polycystic kidney disease (PKHD1-related)
|
PKHD1 |
Polymicrogyria (ADGRG1-related)
|
ADGRG1 |
POMGNT1-related disorders (including muscle eye brain disease)
|
POMGNT1 |
Pontocerebellar hypoplasia (RARS2-related)
|
RARS2 |
Pontocerebellar hypoplasia (SEPSECS-related)
|
SEPSECS |
Pontocerebellar hypoplasia (VRK1-related)
|
VRK1 |
Postnatal progressive microcephaly with seizures and brain atrophy/infantile cerebral and cerebellar atrophy
(MED17-related)
|
MED17 |
Primary carnitine deficiency
|
SLC22A5 |
Primary ciliary dyskinesia (DNAH5-related)
|
DNAH5 |
Primary ciliary dyskinesia (DNAI1-related)
|
DNAI1 |
Primary ciliary dyskinesia (DNAI2-related)
|
DNAI2 |
Primary hyperoxaluria type 1
|
AGXT |
Primary hyperoxaluria type 2
|
GRHPR |
Primary hyperoxaluria type 3
|
HOGA1 |
Progressive familial intrahepatic cholestasis type 2
|
ABCB11 |
Propionic acidemia (PCCA-related)
|
PCCA |
Propionic acidemia (PCCB-related)
|
PCCB |
PRPS1-related conditions (including Charcot-Marie-Tooth disease type 5 and Arts syndrome) |
PRPS1 |
Pycnodysostosis
|
CTSK |
Pyruvate carboxylase deficiency
|
PC |
Pyruvate dehydrogenase deficiency (PDHA1-related) |
PDHA1 |
Pyruvate dehydrogenase deficiency (PDHB-related) |
PDHB |
Retinitis pigmentosa 25
|
EYS |
Retinitis pigmentosa 26
|
CERKL |
Retinitis pigmentosa 28
|
FAM161A |
Rhizomelic chondrodysplasia punctata type 1/Refsum disease (PEX7-related)
|
PEX7 |
Rhizomelic chondrodysplasia punctata type 3 |
AGPS |
Roberts syndrome
|
ESCO2 |
Sandhoff disease
|
HEXB |
Schimke immuno-osseous dysplasia
|
SMARCAL1 |
Severe combined immune deficiency (DCLRE1C-related)
|
DCLRE1C |
Severe combined immunodeficiency/Omenn syndrome (RAG2-related)
|
RAG2 |
Severe combined immunodeficiency, X-linked (X-SCID) |
IL2RG |
Severe congenital neutropenia (VPS45-related) |
VPS45 |
Sialic acid storage conditions
|
SLC17A5 |
Sjögren-Larsson syndrome
|
ALDH3A2 |
SLC26A2-related conditions (including diastrophic dysplasia, atelosteogenesis type 2, achondrogenesis type
1B/multiple metaphyseal dysplasia)
|
SLC26A2 |
SLC35A3-related conditions
|
SLC35A3 |
Smith-Lemli-Opitz syndrome
|
DHCR7 |
Spastic paraplegia type 15
|
ZFYVE26 |
Spastic paraplegia type 49
|
TECPR2 |
Spinal muscular atrophy
|
SMN1 |
Spondylothoracic dysostosis |
MESP2 |
Steel syndrome |
COL27A1 |
Stüve-Wiedemann syndrome
|
LIFR |
Tetrahydrobiopterin deficiency (PTS-related)
|
PTS |
Transient infantile liver failure (TRMU-related)
|
TRMU |
Tyrosine hydroxylase deficiency
|
TH |
Tyrosinemia type I
|
FAH |
Tyrosinemia type II
|
TAT |
Usher syndrome type 1F/PCDH15-related conditions
|
PCDH15 |
Usher syndrome type IB
|
MYO7A |
Usher syndrome type IC/USH1C-related conditions
|
USH1C |
Usher syndrome type ID
|
CDH23 |
Usher syndrome type IIA/USH2A-related conditions
|
USH2A |
Usher syndrome type IIIA
|
CLRN1 |
Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency
|
ACADVL |
Wilson disease
|
ATP7B |
WNT10A-related conditions
|
WNT10A |
Xeroderma pigmentosum (complementation group A)
|
XPA |
Xeroderma pigmentosum (complementation group C)
|
XPC |
Zellweger spectrum disorder (PEX10-related)
|
PEX10 |
Zellweger spectrum disorder (PEX12-related)
|
PEX12 |
Zellweger spectrum disorder (PEX1-related)
|
PEX1 |
Zellweger spectrum disorder (PEX2-related)
|
PEX2 |
Zellweger spectrum disorder (PEX6-related)
|
PEX6 |